The Conversation (0)
WINNIPEG, MANITOBA–(Marketwired – Sept. 12, 2013) – Miraculins Inc. (TSX VENTURE:MOM), (“Miraculins” or the “Company”) a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment …
WINNIPEG, MANITOBA–(Marketwired – Sept. 12, 2013) – Miraculins Inc. (TSX VENTURE:MOM), (“Miraculins” or the “Company”) a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, today announces a non-brokered private placement offering (the “Offering”) of up to 16,666,666 units (“Units”) at a price of $0.06 per Unit for gross proceeds of up to $1,000,000. Each Unit will be comprised of one common share of the Company (a “Share”) and one half of one Share purchase warrant. Each whole warrant (a “Warrant”) will entitle the holder to purchase one Share at a price of $0.10 per Share for a period of 12 months from the date the Warrant is issued.
View the full press release here.